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Mast cells have long been recognized to have a direct and critical role in allergic and inﬂammatory reactions. In allergic diseases,
thesecellsexert bothlocalandsystemicresponses,includingallergicrhinitisandanaphylaxis.Mastcell mediatorsarealsorelatedto
many chronic inﬂammatory conditions.Besides the roles in pathological conditions,the biological functions of mast cells include
roles in innate immunity, involvement in host defense mechanisms against parasites, immunomodulationof the immune system,
tissuerepair, and angiogenesis.Despite their growing signiﬁcancein physiological andpathological conditions,much still remains
to be learned about mast cell biology. This paper presents evidence that lipid rafts or raft components modulate many of the
biological processes in mast cells, such as degranulation and endocytosis, play a role in mast cell development and recruitment,
and contribute to the overall preservation of mast cell structure and organization.
1.Introduction
Mast cells, like blood cells, are derived from pluripotent
bone marrow hematopoietic stem cells but, unlike blood
cells, they leave the bone marrow as progenitors and migrate
into virtually all vascularized tissues to complete their
diﬀerentiation under the inﬂuence of factors present at each
tissue site. It is the microenvironment surrounding the mast
cells that determines their mature phenotype [1–6]. Mast
cells are eﬀector cells of allergic and anaphylactic reactions
and play a role in many physiological and pathological
processes [7, 8]. Recently, they have gained new importance
as immunoregulatory cells with the recognition that they
a r eam a j o rs o u r c eo fc y t o k i n e sa n dc h e m o k i n e sa n dp l a y
roles in both innate and adaptive immunities [7, 9, 10].
Although mast cells may be activated by a number of
stimuli and pathways [11, 12], the major mechanism for
their activation and subsequent degranulation is through
the high-aﬃnity receptor for immunoglobulin E (FcεRI),
present in the plasma membrane of mast cells, epidermal
Langerhans cells, eosinophils, and basophils [13]. FcεRI
is expressed as a heterotetrameric structure composed of
one α subunit with an extracellular domain that binds
IgE, a four-transmembrane-spanning β subunit, and two
identicaldisulphidelinkedγ subunits[14–17].Theβsubunit
serves as an important ampliﬁer of IgE and antigen-induced
signaling events. Furthermore, the γ subunits are essential
for initiating signaling events downstream of FcεRI [17, 18].
The carboxyl terminal cytoplasmic domains of both the
β and γ subunits contain an immunoreceptor tyrosine-
based activation motif (ITAM), common to all multisub-
unit immune recognition receptors, that is critical for cell
activation. Because the receptor subunits lack any known
enzymatic activity, FcεRI must rely on associated molecules
for transducing intracellular signals [16, 19, 20]. Mast cell
activation is initiated by the binding of oligomeric antigens
to receptor-bound IgE, which crosslinks FcεRI and results
in its aggregation. The ﬁrst recognized biochemical event of
the cytoplasmic signal transduction cascade involves phos-
phorylation, presumably by Lyn, of two conserved tyrosine
residues within the ITAMs of both β and γ subunits of the
receptor. The tyrosine-phosphorylated ITAMs create a novel
binding surface that is recognized by additional cytoplasmic
signaling molecules, such as the protein tyrosine kinase Syk2 Journal of Lipids
which binds mainly to the γ subunit, via its tandem Src
homology 2 (SH2) domains. This interaction results in a
conformational change in Syk, followed by its activation
and autophosphorylation. This results in an increased kinase
activity that rapidly shifts the equilibrium of the cell from a
resting state (where phosphorylation and dephosphorylation
activities are approximately equal) to an activated state
(where phosphorylation activity increases exponentially and
cannot be counteracted by dephosphorylation). This Syk-
mediated signal ampliﬁcation results in a direct or indirect
activation of several proteins, including linker for activation
of T cells (LAT), Vav, phospholipase C-γ1( P L C - γ1), and
PLC-γ2. Finally, downstream activation resultsin an increase
in intracellular calcium levels, activation of other enzymes
and adaptors, and rearrangement of the cytoskeleton that
culminates in the release of three classes of mediators: (1)
preformed mediators (stored in secretory granules), such
as histamine, heparin, β-hexosaminidase, neutral proteases,
acid hydrolases, major basic protein, carboxypeptidases, and
some cytokines and growth factors, (2) newly formed lipid
mediators, such as prostaglandins and leukotrienes, and (3)
newly synthesized mediators, that include growth factors,
cytokines, and chemokines [14, 21, 22]. Accumulating
evidence suggests that lipid rafts or raft components play a
pivotal role in signal transduction via FcεRI in mast cells and
thattheorganization ofvarious moleculesin lipidrafts could
modulate many biological processes in these cells.
Lipid rafts, present in all eukaryotic cells, are currently
deﬁnedasdynamic-ordered nanoscale assembliesofproteins
and lipids of the plasma membrane and other intracellular
membranes, such as Golgi membranes, that associate and
dissociate on a subsecond timescale [4, 23, 24]. They
contain high levels of cholesterol, sphingolipids (such as
sphingomyelin), and gangliosides. Lipid rafts selectively
concentrate glycosylphosphatidylinositol- (GPI-) anchored
proteins on their outer side and proteins anchored by
saturated palmitoyl or myristoyl groups and cholesterol-
binding proteins on the cytoplasmic side [25–29]. Their
lipidcomposition(Figure 1),witha preponderanceoflonger
saturated hydrocarbon chains that potentiate interdigitation
between leaﬂets [30] and favors interaction with cholesterol
[31], allows cholesterol to be tightly intercalated. Lipid rafts
are highly organized and probably exist in a liquid-ordered
(lo)p h a s e ,d i ﬀerent from the rest of the plasma membrane
which consists mainly of phospholipids (with unsaturated
tails) in a liquid-disordered (ld)p h a s e[ 32]. The extent of
packing depends on the degree of saturation. The cis double
bondpresentonunsaturatedlipidsintroducesarigidbendin
the hydrocarbon tail which interferes with the tight packing
and results in less stable aggregates [33]. Lipid rafts are
characterized by high melting temperature and a resistance
to solubilization in nonionic detergents such as Triton X-
100, at low temperature [34]. They are dynamic in that both
proteins and lipids can move in and out of raft domains with
diﬀerent partitioning kinetics [28], as well as by coalescing
or by breaking up into smaller units [29]. Lipid rafts can also
form stabile platforms that are important in signaling, viral
infection, and membrane traﬃcking [24]. Despite a body of
evidence supporting the existence of raft domains, the raft
concept is still being debated [35] because the mechanisms
thatgoverntheassociationsamongsphingolipid,cholesterol,
and speciﬁc membrane proteins in live cell membranes
remain unclear [36]. The controversy is largely due to the
lack of standardized methodology for lipid raft studies and
the diﬃculty in proving deﬁnitively that rafts exist in living
cells without causing signiﬁcant nonphysiological pertur-
bations by using low temperatures or by extensive cross-
linking [37]. The majority of the studies involving lipid rafts
begin with detergent solubilization of whole cells followed
by sucrose density gradient centrifugation and the recovery
of detergent-resistant membranes from the light fractions
of the gradient [19, 20]. However, the analysis of density
gradient centrifugation experiments remains controversial
because there is an indication that detergents may force
associations between components that are not colocalized
in intact cells [38]. Fractionation results are also known to
be severely altered by varying the concentration of Triton
X-100 [39, 40], by the use of diﬀerent detergents, [41, 42],
or by omission of detergents in general [43–45]. Another
diﬃculty has been demonstrating the coexistence of lo and
ld phases in live cells. However, technological advances
have produced compelling data that self-organization of
lipidsandproteinscaninducesubcompartmentalizationthat
organizes the bioactivity of cell membranes [31]. Recently,
the lipid-based phase separation into liquid-ordered-like
and liquid-disordered-like phases has been seen in giant
plasma membrane vesicles (GPMVs) obtained by chemically
induced blebbing from cultured cells [46, 47]o rb yu s i n g
cell swelling to generate plasma membrane spheres (PMS)
[48]. In 2010, Johnson et al. [49]u s i n gG P M V ss h o w e d
that peripheral protein binding may be a regulator for
lateral heterogeneity in vivo. These new approaches are very
promising, allowing studies of the lipid domains in the
absence of detergents and other perturbations of membrane
structure. Advances in imaging and studies with improved
integrated methodologies, such as ﬂotation of detergent-
resistant membranes, antibody patching and immunoﬂuo-
rescence microscopy, immunoelectron microscopy, chemical
crosslinking, single ﬂuorophore tracking microscopy, pho-
tonic force microscopy, spectroﬂuorimetry, mass spectrome-
try, and ﬂuorescence resonance energy transfer (FRET) are
now providing insights into the existence and behavior of
lipid rafts [2, 16, 24, 50–56].
The lipid microdomains are variable in stability, size,
shape, lifetime, and molecular composition [29, 37]. Due
to diﬀering molecular composition, studies of lipid rafts
have also been complicated by imprecise nomenclature [24].
For example, caveolae was synonymous with lipid rafts for
many years. In 1998, Harder et al. [57], using a cell system
lackingcaveolae,demonstratedthatraftand nonraft markers
segregated in the same cholesterol-dependent way in the
absence of caveolae. These results showed that clustered
raft markers segregate away from nonraft proteins in a
cholesterol-dependent, but caveolin independent manner
[56]. Today caveolae are considered a subset of lipid rafts
[16, 58].
Membrane rafts in most cell types are enriched with sig-
nalingmoleculesbyvirtueoftheaﬃnityofsignalingproteinsJournal of Lipids 3
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Figure 1: Diagrammatic representation of a lipid raft. Lipid rafts are enriched in cholesterol, sphingolipids,and gangliosides.GPI anchored
proteins, sphingomyelin, phosphatidylcholine and gangliosides are present in the outer membrane leaﬂet. Prenylated proteins, acylated
proteins, phosphatidlyserine, and phosphatidylethanolamine are present in the inner leaﬂet. Cholesterol is present in both leaﬂets and
functions as a space ﬁlling molecule under the sphingolipid head groups. TM1, TM2, Transmembrane proteins 1 and 2.
including transmembrane receptors, GPI anchored proteins,
G proteins, RhoA and Src kinases for rafts [1, 35]. The
number of proteins reported to be regulated by speciﬁc lipid
interaction is steadily increasing, but the precise structural
mechanisms behind speciﬁc binding and receptor regulation
in membranes remain uncharacterized [56]. A wealth of
biochemicalandgeneticdatahavelentcredencetothenotion
that raft function as a specialized signaling platform in cell
membranes [59–65]. Most likely, the function of rafts is
aided by stimulation-induced association and recruitment
of various molecules with raft aﬃn i t y ,a sw e l la sv a r y i n g
degrees of raft engagement with the cytoskeleton [3, 4, 29].
Lipid rafts are also thought to be important sites for protein
tyrosine kinase-mediated protein-protein interactions that
are involved in the initiation of receptor signaling pathways
[5, 6, 16]. It is well known that, in thec a s eo ft y r o s i n ek i n a s e
receptors, adaptors, scaﬀolding proteins, and enzymes are
recruited to the cytoplasmic side of the plasma membrane
as a result of ligand binding to form a signaling complex
[66]. If receptor activation takes place in an ordered lipid
raft, the signaling complex is protected from other proteins,
such as membrane phosphatases, localized in the disordered
region of the plasma membrane, that otherwise could aﬀect
the signaling process [35, 51, 67]. Lipid rafts are implicated
in the function of diverse signaling pathways such as those
mediated by growth factors, morphogens, integrins [16]a n d
antigen receptors on immune cells, including mast cells [68–
71]. The structural basis for the association of FcεRI with
lipid rafts is partially understood and appears to involve
the transmembrane segments of FcεRI α and/or γ subunits.
However, the structural features of FcεRI that mediate
the detergent-sensitive interaction with lipid rafts occur
selectively but not uniquely with this receptor [39]. Both β
and γ subunits are palmitoylated, which could facilitate their
association with lipid rafts [72].
Studies have shown that establishing and maintaining
lipid rafts is important for many biological processes besides
cell signaling [73, 74]. These membrane microdomains have
been implicated in such processes as exocytosis, endocytosis,
membrane traﬃcking, and cell adhesion. The structure-
function relationship of lipid rafts or rafts constitutes are
important in various aspects of mast cell biology.
2.Morphology
The ability to form lipid rafts appears to be important for
maintaining the typical morphology of mast cells. Ganglio-
sides (Figure 2), lipid raft components, are complex gly-
cosphingolipids that are ubiquitous membrane constituents
[5, 75–77] and seem to be structurally important for lipid
raft assembly and function. The rigid structural nature of
the ceramide anchor in gangliosides, coupled with the ability
of sphingolipids to associate with cholesterol, is thought to
drive the assembly of lipid rafts [16, 78].
The inﬂuence of gangliosides and/or lipid rafts on cell
structure and organization was examined [79]u s i n ga
ganglioside-deﬁcient cell line, D1, and the parent cell line,
RBL-2H3, a cell line with homology to mucosal mast cells4 Journal of Lipids
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Figure 2: Diagrammatic representation of ganglioside GD1b.T h e
ganglioside is composed of a carbohydrate head group and a
hydrophobic lipid tail.
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Figure 3: Ganglioside-deﬁcient D1 cells have an altered morphol-
ogy. By scanning electron microscopy, RBL-2H3 cells are spindle
shaped and their surface is covered with short microvilli. In
contrast,D1 cellsare rounded andtheirsurface iscovered withlarge
membrane ruﬄes.
[80–84]. The D1 cell line is deﬁcient in GM1 gangliosides
and in mast cell speciﬁc α-galactosyl derivatives of the gan-
gliosideGD1b.T h eα-galactosyl derivatives ofthe ganglioside
GD1b, antigens I and II, contain, respectively, one and two
additional α-galactosyl residues when compared with GD1b.
These unique gangliosides are present on the surface of
rodent mast cells and are speciﬁcally recognized by the
monoclonal antibody (mAb) AA4 [85]. These gangliosides
derived from GD1b have been identiﬁed as components of
lipidraftsintheplasmamembraneofRBL-2H3cells[86,87].
The mutantcellline D1showed acellularmorphologywhich
is distinct from RBL-2H3 cells (Figure 3), suggesting that the
gangliosides are important in the maintenance ofnormal cell
morphology.
The morphological changes observed in D1 cells could
be related to the lipid composition of these cells. This cell
line presents a large decrease in glycosphingolipids, such
as GM1 and the α-galactosyl derivatives of the ganglioside
GD1b,w h i c hm a ya ﬀect many physicochemical properties
of the plasma membrane. According to Kato et al. [88],
the lipid composition could inﬂuence membrane stability,
membrane ﬂuidity, lipid packing, bilayer curvature, and
hydration elasticity, as well as anchorage of the cytoskeleton
to the plasma membrane. Silveira e Souza et al. [79]a l s o
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Figure 4: The F-actin distribution in RBL-2H3 and D1 cells
reﬂects their morphology. Actin ﬁlaments in RBL-2H3 cells lie
under the plasma membrane following the spindle shape of the
cells and in association with microvilli. The actin cytoskeleton is
altered in D1 cells and the actin ﬁlaments are concentrated in large
membrane ruﬄes. The cells were ﬁxed, permeabilized, and stained
with phalloidin conjugated to Alexa 488. Samples were examined
using a Leica TCS-NT laser scanningconfocal microscope.
observed that the D1 cells showed an abnormal distribution
of actin ﬁlaments and microtubules. A growing body of
evidenceindicatesthatlipidraftsareessentialformembrane-
cytoskeleton coupling, and the association of Lyn and
other raft markers with crosslinked FcεRI is regulated by
interactions with F-actin [89–91]. It is possible that in the
D1 mutant cells, the disorganization of both lipid rafts and
actin ﬁlaments (Figure 4) leads to impaired degranulation
after FcεRI stimulation [79, 87]. Furthermore, the actin
cytoskeleton is known to participate in regulating and
activating raft-associated signaling events [92–94].
The factors that govern the formation of lipid rafts
continue to be elucidated, but lipid raft formation often
requires actin ﬁlaments. The connection between lipid raft
proteins andactin ﬁlaments canaﬀectthelateraldistribution
and mobility of these membrane proteins [59, 95]. The
extent to which the actin cytoskeleton participates in the
formation of membrane rafts is not yet established. Han
et al. [96] observed that perturbations in the actin ﬁla-
ments (with cytochalasin D and latrunculin A) aﬀect the
organization of lipid rafts in RBL-2H3 cells. Importantly,
the actin cytoskeleton is a dynamic structure that changes
in response to extracellular signals, and it may therefore
represent one mechanism for governing the establishment
and distribution of lipid rafts in the plasma membrane [97].
Chichili and Rodgers [98] showed that lipid rafts may be
structured by a synergistic interaction between the cortical
actin ﬁlaments and the lipid rafts themselves, and that many
of the structural and functional properties of rafts require
an intact actin cytoskeleton. An important regulator of
membrane-cytoskeletoninteractionsis thephosphoinositide
PIP2, which is a minor lipid component of the plasma
membrane that is known to regulate the organization of
the actin cytoskeleton and in particular the formation of
actin-membrane linkages [99]. PIP2 also serves as a cofactor
for many of the proteins that anchor actin ﬁlaments to
t h ep l a s m am e m b r a n e[ 99, 100]. Protein binding to PIP2
often occurs through a PIP2-speciﬁc recognition sequence,
in many cases represented by a PIP2-speciﬁc pleckstrinJournal of Lipids 5
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Figure 5: The gangliosides follow the same endocytic pathway
as FcεRI. At 15 minutes of incubation with both mAb BC4-
gold (which recognizes the α subunit of FcεRI) and mAb AA4-
HRP (which recognizes gangliosides derived from GD1b), the BC4-
gold (arrows) and AA4-HRP (arrowheads) are colocalized in early
endosomes adjacent to the plasma membrane (PM).
homology (PH) domain [101–103]. Some actin binding
proteins(ABPs)arethoughttolink actinﬁlaments andPIP2-
enriched rafts. Gelsolin is one of the ABPs present in lipid
rafts [104]. Microtubules are one of the major determinants
of cell shape and polarity [105, 106]. In the ganglioside-
deﬁcient D1 cells, the arrangement of microtubules was
completely disorganized. The results from this study have
demonstrated that the abnormal morphology observed in
the mutant cell line could be related to the decrease in
gangliosides that leads to lipid raft disorganization [79].
3.Endocytosis
When the concept of lipid rafts and the mobility of proteins
i nt h ep l a s m am e m b r a n eo r i g i n a t e d ,i tw a so b s e r v e dt h a t
plasma membrane associated proteins couldsuﬀeraselective
reorganization followed by internalization of these proteins
[107–109]. Receptor-mediated endocytosis, including endo-
cytosis of FcεRI, is a temporally and spatially organized
process[22,110].Afteractivation, crosslinkedFcεRIisendo-
cytosed through clathrin-coated vesicles and transported by
the endosomal system for eventual degradation in lysosomes
[111–113]. In unstimulated mast cells, FcεRI is dispersed
throughout the plasma membrane but upon activation the
receptors rapidly aggregate and can be found on the cell
surface in lipid rafts in association with GM1 [114, 115],
gangliosides derived from GD1b, protein tyrosine kinase Lyn
and LAT, [22, 39, 86]. However, only when the mast cells are
activated via FcεRI does a signiﬁcant internalization of the
GD1b derivatives occur [22, 116]. The endocytosis process
itself may play an important role in signal transduction [110,
117]. Oliver et al. [22] showed that upon activation of FcεRI,
the gangliosides derived from GD1b are internalized together
with the receptor, following the same pathway to lysosomes
(Figure 5). This may facilitate the structural preservation of
signaling complexes and the prolongation of the signal since
these gangliosides and the FcεRI are associated in lipid rafts.
In view of the importance of lipid raft integrity for
eﬃcient receptor endocytosis, it has been observed that the
FcεRI ubiquitination is a key mechanism for the regulation
and control of antigen-dependent endocytosis of receptor
complexes [118]. Moreover, it has been demonstrated that
ubiquitin ligases Cbl and Nedd4 are recruited into lipid rafts
upon IgE triggered cell signaling [119]. Nedd4 was shown
to ubiquitinate membrane receptors [120]. The ubiquitin
C b li sag o o dc a n d i d a t et om e d i a t eF c εRI ubiquitination
since it participates in various functions such as cis-and-
trans-ubiquitination [121]. It is phosphorylated upon FcεRI
engagement [122] and negatively regulates Syk kinase [123].
Molfetta et al. [124, 125] suggested that the recruitment
of engaged FcεRI subunits into lipid rafts precedes their
ubiquitination, and that integrity oflipid rafts is required for
receptor ubiquitination and endocytosis, contributing to the
down-regulation of FcεRI-mediated signaling.
4.Signal Transduction
In mast cells, the ﬁrst signaling complex convincingly shown
to involve lipid rafts was immunoglobulin E (IgE). IgE
signaling wasinitiallythoughttobebasedonprotein-protein
interactions alone, but several observations indicated that
lipid rafts are involved in this process [37, 68, 126–131]. The
ﬁrst hintcamefromtheﬁndingthatFcεRIissolubleinTriton
X-100 at steady state but becomes insoluble in low concen-
trations of this detergent after crosslinking [68]. Moreover,
in unstimulated cells, FcεRI is dispersed throughout the
plasma membrane, but upon activation rapidly aggregates
[115, 132] and can then be found on the cell surface in
associationwiththegangliosideGM1 [57,114,133]andGPI-
anchored proteins [89, 134]. Despite numerous studies on
mast cell activation through FcεRI, the detailed mechanism
by which cross-linking promotes the initial phosphorylation
by Lyn and the molecular mechanisms for Lyn activation are
still unclear [67, 77, 135, 136]. Davey et al. [37] suggested
that protein-protein interaction (IgE-FcεRI cross-linking)
recruits essential signaling proteins and lipid molecules into
more ordered domains that serve as a platform for signaling.
An approach intensively used to better understand the
role of lipid rafts in FcεRI-mediated signaling has been the
study and/or the manipulation of the lipid constituents of
rafts, such as cholesterol and gangliosides [16, 87, 136].
Methyl-β-cyclodextrin (MβCD), a carbohydrate molecule
with a pocketfor binding cholesterol, [16]is extensively used
to deplete the surface cholesterol and subsequently disrupt
lipid rafts. MβCD has been used to study the role of lipid
rafts in FcεRI-mediatedsignaling, particularly in early events
of signal transduction such as tyrosine phosphorylation of
FcεRI by Lyn [136]. Sheets et al. [86]h a v ed e m o n s t r a t e d
that phosphorylation of FcεRI proceeds in a cholesterol-
dependent manner and that cholesterol depletion reduces
stimulated tyrosine phosphorylation of FcεRI. In parallel
to its inhibition of tyrosine phosphorylation, cholesterol
depletion disrupts the interactions of aggregated FcεRI and
Lyn in intact cells. Cholesterol repletion restores receptor
phosphorylation together with the structural interactions,
providing strong evidence that lipid raft structure, main-
tained by cholesterol, plays a critical role in the initiation of
FcεRIsignaling.CholesteroldepletionbyMβCDinRBL-2H3
cells also reduced the release of β-hexosaminidase activity6 Journal of Lipids
in cells stimulated via FcεRI [87, 88, 137, 138]. These
data suggest that the cholesterol depletion by MβCD aﬀects
the IgE signaling due to the disruption of lipid rafts and
consequentlyresults in a failure to form a signaling complex.
Moreover, Young et al. [67] showed evidence that Lyn
isolated in lipid rafts has substantially higher Lyn kinase
activity than Lyn outside of these membrane microdomains.
These data suggest that some unknown components in lipid
rafts may inﬂuence the kinase activity of Lyn [136]a n d
subsequently FcεRI signal transduction.
Flotillin-1 is another constituent of lipid rafts [139,
140]. It was initially identiﬁed as a caveolae-associated
membrane protein and is a marker protein of lipid rafts,
but its physiological role is still not clear. Kato et al. [136]
using ﬂotillin-1 knockdown RBL-2H3 cells showed that
ﬂotillin-1 regulates the kinase activity of Lyn in mast cells.
In the ﬂotillin-1 knockdown cells, there was a signiﬁcant
decrease in Ca2+ mobilization, the phosphorylation of ERKs,
tyrosine phosphorylation of the γ-subunit of FcεRI, and
IgE-mediated degranulation. This study also showed that
ﬂotillin-1 is constitutively associated with Lyn in lipid rafts
in RBL-2H3 cells, and that antigen stimulation induced an
increase in ﬂotillin-1 binding to Lyn, resulting in enhance-
mentofthekinaseactivityofLyn.Thesedatasuggestthatthis
raft protein is an important component of FcεRI-mediated
mast cell activation and regulates thekinase activity of Lyn in
lipid rafts.
The α-galactosyl derivatives of the gangliosides GD1b
also seem to be intimately involved with signaling through
FcεRI. Although the functional role of these gangliosides
is not clear, previous studies have shown that when the
α-galactosyl derivatives of ganglioside GD1b are bound by
mAb AA4, histamine release was inhibited in a time- and
concentration-dependent manner. Binding of mAb AA4
to RBL-2H3 cells resulted in an increase in intracellular
calcium, phosphatidylinositol hydrolysis, and a redistribu-
tion of PKC. However, the magnitude of these changes
w a sl e s st h a nt h o s ea f t e rF c εRI aggregation, and unlike
FcεRI activation, these changes were not accompanied by
histamine release [81]. The derivatives of the ganglioside
GD1b coprecipitated with the Src family tyrosine kinase Lyn
a n dt h a ti ns p i t eo ft h ef a c tt h a tm A bA A 4b i n d st os i t e sc l o s e
to FcεRI the association between Lyn and these gangliosides
was not mediated by FcεRI. The association of Lyn with
these gangliosides is much stronger than the association of
Lyn with FcεRI. These associations suggest that a complex
of molecules that includes gangliosides, FcεRI, and Lyn is
essential for modulation of signal transduction in mast cells
[81, 141–144].
Furthermore, analysis of the subcellular distribution of
the gangliosides recognized by mAb AA4 and of FcεRI on
sucrose gradients showed that, following FcεRI activation,
there was a shift in the distribution of the gangliosides to
the lipid raft fractions [22, 87]. The movement of these
gangliosides into the lipid rafts may be another mechanism
that regulates signal transduction in mast cells.
As previously stated, using a cell line deﬁcient in
the α-galactosyl derivatives of ganglioside GD1b,a sw e l l
as the parent cell line, RBL-2H3, Silveira e Souza et al.
[87] demonstrated and conﬁrmed the importance of these
gangliosides for lipid raft organization and consequently
for FcεRI-mediated degranulation in rodent mast cells. In
this study, the authors observed a decreased release of β-
hexosaminidase activity in the mutant cell line after FcεRI
stimulation, but not after exposure to calcium ionophore.
These results show that release of β-hexosaminidase activity
is calcium-dependent and furthermore indicated that the
mutant cell line possesses the capacity to degranulate. More-
over, reduced release of β-hexosaminidase activity in RBL-
2H3 cells treated with compounds that inhibit ganglioside
synthesis was also observed.
In addition to lipid raft assembly, another possible role
for the mast cell-speciﬁc gangliosides in signal transduction
could be to facilitate the association of Lyn with FcεRI.
Because FcεRI itself has no intrinsic kinase activity, the
tyrosine phosphorylations induced by receptor cross-linking
could be a secondary event that occurs after aggregation of
FcεRI and its movement into lipid rafts [143]. Therefore,
these lipid raft complexes that include gangliosides, associ-
ated proteins, such as Lyn, LAT, ﬂotillin-1 and FcεRI, havean
important role in receptor-mediated signal transduction.
Recently, Fifadara et al. [8] reported that mast cells
produce structures such as cytonemes or tunneling nan-
otubes used for intercellular communication and that inter-
cellular communication may be important during allergic
and inﬂammatory responses following costimulation of
FcεRI and CCR1. Albeit the process of cytoneme formation
remains poorly understood, the fact that cholesterol deple-
tion reduced the formation of cytonemes suggests that lipid
rafts may participate in cytoneme formation in mast cells,
either by promoting membrane integrity or by participating
in cell signaling.
5.Mast Cell Developmentand Recruitment
The expression of the α-galactosyl derivatives of the ganglio-
side GD1b on the mast cell surface also appears to be related
to mast cell development and recruitment. Previous studies
using mAb AA4 showed that the α-galactosyl derivatives of
the ganglioside GD1b were present only in mast cells and
not in any other cell type in all 23 rat tissues examined
[81, 85]. However, in bone marrow, a population of large,
poorly diﬀerentiated cells, presumably immature mast cells
were also stained with mAb AA4 [81]. Later these cells were
indeed shown to be very immature and immature mast cells
[145, 146]. Since the heterogeneity of the maturing mast
cells makes them impossible to separate from other cells
on the basis of their density and mAb AA4 binds only to
cells which can be identiﬁed as mast cells [146, 147], the
gangliosides recognized by mAb AA4 may be considered a
powerful marker for rodent mast cells.
The ability to characterize the maturation of bone
marrow-derived and peritoneal mast cells has been impaired
both by the lack of mast cell-speciﬁc markers and by the
inability to rapidly and eﬃciently separate mast cells in all
stages of maturation from a mixed population of cells [148].
UsingmAbAA4conjugatedtotosylactivatedDynabeads450,
Jamur et al. [145] successfully separated mast cells fromJournal of Lipids 7
rat bone marrow and the peritoneal lavage. They [146]
then went on to isolate and characterize bone marrow mast
cells at various stages of maturation. In this study, the
very immature mast cells, which had not been previously
described, were identiﬁed by the presence of the derivatives
of the ganglioside GD1b on their surface. These cells which
could not be recognized as mast cells by standard cytological
methods contained only a few small cytoplasmic granules.
On the other hand, undiﬀerentiated mast cell precursors in
t h eb o n em a r r o wd on o te x p r e s st h eα-galactosyl derivatives
of the ganglioside GD1b recognized by mAb AA4. These
gangliosides begin to be expressed on the cell surface jointly
with FcεRI and at the same time as the initiation of the
formation of cytoplasmic granules in very immature mast
cells. The gangliosides derived from GD1b continue to be
expressed by mast cells in all stages of maturation [149].
These data suggest that mast cell lipid rafts or raft constitutes
are related to mast cell maturation and function.
6.Conclusions
Several aspects of raft structure and function in mast cell
biology still need to be elucidated. Undoubtedly, lipid rafts
and their constitutes play a role in many aspects of mast
cell biology, such as activation through FcεRI, morphology,
endocytosis, and maturation. Further research to better
deﬁne the role of lipid rafts in mast cells could oﬀer novel
targets for immunotherapies and treatment of diseases in
which mast cells and/or their mediators are involved.
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